G. Deutschinoff

559 total citations
9 papers, 408 citations indexed

About

G. Deutschinoff is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Internal Medicine. According to data from OpenAlex, G. Deutschinoff has authored 9 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 4 papers in Surgery and 4 papers in Internal Medicine. Recurrent topics in G. Deutschinoff's work include Venous Thromboembolism Diagnosis and Management (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Pancreatic and Hepatic Oncology Research (3 papers). G. Deutschinoff is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Pancreatic and Hepatic Oncology Research (3 papers). G. Deutschinoff collaborates with scholars based in Germany. G. Deutschinoff's co-authors include Ludger Pientka, T Scholten, P Reitzig, S. Hahnfeld, Helmut Oettle, Uwe Pelzer, Bernhard Opitz, Martina Stauch, Jens Stieler and Hanno Riess and has published in prestigious journals such as Journal of Clinical Oncology, Critical Care Medicine and Critical Care.

In The Last Decade

G. Deutschinoff

9 papers receiving 388 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Deutschinoff Germany 8 232 198 145 98 88 9 408
F Fabrega United States 5 340 1.5× 209 1.1× 78 0.5× 122 1.2× 183 2.1× 6 537
Reina Valle Spain 11 526 2.3× 308 1.6× 172 1.2× 70 0.7× 194 2.2× 19 605
Tom Vlasveld Netherlands 5 311 1.3× 214 1.1× 34 0.2× 103 1.1× 64 0.7× 8 406
Ghazi Alotaibi Saudi Arabia 12 408 1.8× 290 1.5× 67 0.5× 61 0.6× 136 1.5× 30 582
Kirill Lobastov Russia 12 360 1.6× 145 0.7× 71 0.5× 50 0.5× 213 2.4× 86 475
Jordan Hill United Kingdom 6 178 0.8× 118 0.6× 31 0.2× 42 0.4× 122 1.4× 10 327
Alexander Cohen United States 3 406 1.8× 293 1.5× 56 0.4× 37 0.4× 87 1.0× 4 455
A. Sampériz Spain 9 529 2.3× 432 2.2× 102 0.7× 72 0.7× 138 1.6× 17 576
John A. Norton United States 7 505 2.2× 397 2.0× 201 1.4× 44 0.4× 366 4.2× 15 827
Jeffrey S. Barton United States 8 194 0.8× 95 0.5× 36 0.2× 49 0.5× 116 1.3× 19 323

Countries citing papers authored by G. Deutschinoff

Since Specialization
Citations

This map shows the geographic impact of G. Deutschinoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Deutschinoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Deutschinoff more than expected).

Fields of papers citing papers by G. Deutschinoff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Deutschinoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Deutschinoff. The network helps show where G. Deutschinoff may publish in the future.

Co-authorship network of co-authors of G. Deutschinoff

This figure shows the co-authorship network connecting the top 25 collaborators of G. Deutschinoff. A scholar is included among the top collaborators of G. Deutschinoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Deutschinoff. G. Deutschinoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Pelzer, Uwe, Bernhard Opitz, G. Deutschinoff, et al.. (2015). Efficacy of Prophylactic Low–Molecular Weight Heparin for Ambulatory Patients With Advanced Pancreatic Cancer: Outcomes From the CONKO-004 Trial. Journal of Clinical Oncology. 33(18). 2028–2034. 187 indexed citations
2.
Riess, Hanno, Uwe Pelzer, G. Deutschinoff, et al.. (2009). A prospective, randomized trial of chemotherapy with or without the low molecular weight heparin (LMWH) enoxaparin in patients (pts) with advanced pancreatic cancer (APC): Results of the CONKO 004 trial. Journal of Clinical Oncology. 27(15_suppl). LBA4506–LBA4506. 52 indexed citations
3.
Pelzer, Uwe, G. Deutschinoff, Bernhard Opitz, et al.. (2009). 6513 Successful prevention of symptomatic thromboembolic events by the low molecular weight heparin enoxaparin in patients with advanced pancreatic cancer – results of the CONKO 004 trial. European Journal of Cancer Supplements. 7(2). 365–365. 2 indexed citations
4.
Riess, H., Uwe Pelzer, G. Deutschinoff, et al.. (2009). A prospective, randomized trial of chemotherapy with or without the low molecular weight heparin (LMWH) enoxaparin in patients (pts) with advanced pancreatic cancer (APC): Results of the CONKO 004 trial. Journal of Clinical Oncology. 27(18S). LBA4506–LBA4506. 13 indexed citations
5.
Riess, H., Uwe Pelzer, G. Deutschinoff, et al.. (2009). A prospective, randomized trial of chemotherapy with or without the low molecular weight heparin (LMWH) enoxaparin in patients (pts) with advanced pancreatic cancer (APC): Results of the CONKO 004 trial. Journal of Clinical Oncology. 27(18_suppl). LBA4506–LBA4506. 19 indexed citations
6.
Deutschinoff, G., et al.. (2005). Lebensqualit�t in der Onkologie. Der Onkologe. 11(2). 164–172. 9 indexed citations
7.
8.
9.
Deutschinoff, G., et al.. (1999). Intensivmedizin bei älteren Patienten: Wie nützlich sind die Scoresysteme APACHE II und III?. Zeitschrift für Gerontologie und Geriatrie. 32(3). 193–199. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F Fabrega Breakdown of academic impact, for papers by Reina Valle Breakdown of academic impact, for papers by Tom Vlasveld Breakdown of academic impact, for papers by Ghazi Alotaibi Breakdown of academic impact, for papers by Kirill Lobastov Breakdown of academic impact, for papers by Jordan Hill Breakdown of academic impact, for papers by Alexander Cohen Breakdown of academic impact, for papers by A. Sampériz Breakdown of academic impact, for papers by John A. Norton Breakdown of academic impact, for papers by Jeffrey S. Barton
Rankless by CCL
2026